GlassScriptPhysician profile
Jason Poteet
NPI 1821208075
$6,999.49
in general payments reported to CMS, 2019-2025
54 companies · $1,248 in 2025
The $1,248 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,133 · 2020: $563 · 2021: $1,443 · 2022: $773 · 2023: $630 · 2024: $1,208 · 2025: $1,248.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,938 · Grant: $114 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,938.01 |
| Grant | $113.64 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,092.33 | 2019-2025 | Xtandi |
| Abbvie INC. | $869.02 | 2019-2025 | |
| Janssen Biotech, INC. | $569.49 | 2019-2024 | Erleada, Akeega |
| Sumitomo Pharma America, INC. | $436.34 | 2023-2025 | Orgovyx, Gemtesa |
| Boston Scientific Corporation | $386.78 | 2019-2025 | Lithovue, Rezum Generator |
| Dendreon Pharmaceuticals LLC | $346.51 | 2020-2025 | Provenge |
| Blue Earth Diagnostics | $245.18 | 2019-2024 | |
| Urogen Pharma, INC. | $216.62 | 2020-2025 | Jelmyto |
| Olympus America INC. | $201.14 | 2024-2025 | Itind System |
| Kerecis Limited | $200.27 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Merck Sharp & Dohme LLC | $185.06 | 2021-2024 | Lynparza, Keytruda |
| Procept Biorobotics Corporation | $170.43 | 2021-2025 | Aquabeam System |
| Progenics Pharmaceuticals, INC. | $161.15 | 2022-2025 | Pylarify |
| Bioprotect Medical, INC. | $151.79 | 2025 | Bioprotect Balloon Implant System |
| Endo Pharmaceuticals INC. | $132.96 | 2020-2023 | Aveed, Xiaflex |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Poteet listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.